Viewing Study NCT01714661


Ignite Creation Date: 2025-12-24 @ 12:21 PM
Ignite Modification Date: 2026-01-28 @ 12:50 PM
Study NCT ID: NCT01714661
Status: COMPLETED
Last Update Posted: 2016-05-03
First Post: 2012-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Sponsor: FORUM Pharmaceuticals Inc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EVP-6124-015
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None INDUSTRY View